Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond the read-only/idempotent annotations by disclosing key behaviors: identifiers are labeled with source, unresolved identifiers appear under `unresolved` rather than omitted, ambiguous matches return `figi_candidates`, non-equity instruments resolve even without a ticker, ISINs map to legal entities via GLEIF, and enrichment degrades gracefully if GLEIF/OpenFIGI are unavailable. This is rich, non-obvious behavioral context an agent needs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense and well-structured with an opening, supported types, and caveats, but it is extremely long and contains extended parentheticals that are hard to parse. Every sentence adds value, but the overall length and nesting hurt readability for an AI agent scanning quickly.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex multi-source resolution tool with no output schema, the description covers accepted inputs, output-related edge cases (candidates, unresolved), source provenance, internal cascading behavior, and graceful degradation. An agent has enough context to call it correctly and interpret ambiguous or partial results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds substantial meaning beyond the schema: it gives concrete examples (AAPL, 0000320193, ozempic, metformin), explains the ISIN input mapping, and provides the critical warning for bond lookups to pass the issuer name exactly as printed rather than the full noun phrase. This goes well beyond the baseline for high schema coverage.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete examples and a clear statement: "resolve a user-spoken NAME to the canonical/official identifiers other tools require as input." It specifies the verb (resolve), the resource (entity names to identifiers), and the scope (company/drug), and distinguishes itself with "Use FIRST whenever you have a name but need an ID." This makes the tool's role unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly states "Use FIRST whenever you have a name but need an ID," and provides detailed context on when each type applies (company vs drug) and what inputs are accepted. However, it does not explicitly name alternatives or state when NOT to use this tool (e.g., when you already have an ID and need entity_profile).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

ask_pipeworx and ask_pipeworx_beta are currently identical in behavior, creating direct overlap. Additionally, the five query/research tools (ask_pipeworx, ask_pipeworx_grounded, deep_research, validate_claim, bet_research) and six Polymarket tools have heavily overlapping boundaries that require reading long descriptions to disambiguate.

Naming Consistency3/5

Names are uniformly snake_case and mostly readable, with consistent domain prefixes (polymarket_*, pipeworx_*) and a verb_noun majority (get_paper, search_papers, resolve_entity). However, bare-verb memory tools (remember, recall, forget) and adjective-noun names (recent_alerts, trending_papers, deep_research) break the dominant convention, making the set mixed though not chaotic.

Tool Count2/5

At 35 tools, this exceeds the 25+ threshold for 'too many,' and several are near-duplicates or overlapping query modes (ask_pipeworx vs ask_pipeworx_beta vs ask_pipeworx_grounded). The server bundles paper search, a universal data router, prediction-market analytics, memory, subscriptions, dependency scanning, and AI visibility into one surface, which feels over-scoped.

Completeness4/5

The surface is quite thorough for its broad domain: querying has grounded/deep/meta variants, companies have profile/compare/change/claim tools, prediction markets have research/edges/arbitrage/fill-risk/spread tracking, and subscriptions/memory have full lifecycles. Minor gaps exist (no full pack catalog listing, no direct fetch-by-URI tool, no paper leaderboards), but agents can work around them via discover_tools/ask_pipeworx.